ImmunoBrain Checkpoint awarded Alzheimer's Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer's disease – GlobeNewswire

ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease  GlobeNewswire
ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease – GlobeNewswire
Source: Nigerian Healthcare Blog